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Abstract 
Aim: To summarize the collective in vitro, in vivo and clinical evidence of the involvement of 
the RANKL-OPG system, a system of two molecules controlling osteoclast differentiation 
and hard tissue resorption, in pulpal and periapical pathophysiology.  
Methodology: A systematic search related to RANKL and/or OPG and pulp or periapical 
disease was conducted on Medline, Biosis, Cochrane, Embase, and Web of Science databases 
using keywords and controlled vocabulary. No language restriction was applied. Two 
independent reviewers first screened titles and abstracts and then the full texts that were 
initially included. The reference lists of the identified publications were examined for 
additional titles. 
Results: A total of 33 papers were identified. In vitro studies (N=11) showed that pulpal cells 
can be stimulated by various inflammatory agents to produce RANKL, whilst many studies 
did not consider the RANKL/OPG ratio. Animal studies (N=9) mostly focused on the time 
course and development of periapical lesions in relation to the RANKL-OPG system. Levels 
of RANKL and OPG in the necrotizing pulp were not investigated. Human studies (N=13) 
showed a steady-state expression of OPG in the odontoblast layer. Conflicting results have 
been reported regarding the role of RANKL in active apical periodontitis, again because the 
correlation of this molecule to its inhibitor (OPG) was often disregarded.  
Conclusions: There is relatively little information currently available that would highlight the 
specific role of RANKL and OPG in pulpal and periapical disease. OPG may play a 
protective role against internal resorption, whilst an increased periapical RANKL/OPG ratio 
might indicate bone resorption. 
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Introduction 
The pathogenesis of pulpal and periapical lesions is largely attributed to host inflammatory 
responses caused by the bacterial infection of the pulp cavity and root canals (Kakehashi et al. 
1965). Inflammation of the dental pulp due to caries, trauma or iatrogenic causes may 
sequentially stimulate periapical inflammation. The inflammatory process is initiated in the 
dental pulp, but may subsequently spread in the periapical region. Persistence of the infection 
in the pulp space may eventually lead to periapical bone resorption. Clinically this manifests 
as apical periodontitis, associated with the formation of cysts and granulomas. 
Histopathologically, apical periodontitis is dominated by dense inflammatory infiltrates and 
increased osteoclast numbers (Nair 2004). A predominant immunological feature in these 
conditions is the massive production of inflammatory mediators, dominated by cytokines of 
the interleukin (IL)-1 family, metabolites of arachidonic acid, such as prostaglandin (PG)E2, 
and neuropeptides (Stashenko et al. 1998). This is considered as a response of the defending 
host, attempting to tackle with the gradually establishing infectious microorganisms. 
Under physiological conditions, a balance between bone formation and resorption is 
established at any site of the skeleton. A local switch in this balance towards enhanced bone 
resorption would result in a bone-related pathology, such as apical periodontitis. When 
considering the molecular mechanisms that control bone resorption, the state-of-art evidence 
demonstrates that the process is controlled by the interplay of Receptor Activator of NF-κB 
Ligand (RANKL) and osteoprotegerin (OPG), belonging to the tumor necrosis factor (TNF) 
ligand and receptor superfamilies, respectively (Lerner 2004). RANKL was initially identified 
as a cell membrane-bound ligand responsible for stimulation of osteoclast differentiation and 
bone resoprtion (Lacey et al. 1998, Kong et al. 1999). Hence, this molecule came into the 
early spot-light as the long-sought osteoclast differentiation factor that mediates the cell-to-
cell interaction between osteoblasts and osteoclast precursors. It is now known that RANKL 
is produced either as a membrane-bound or a secreted ligand by osteoblasts, fibroblasts, or 
 4 
activated T- and B-cells (Lerner 2006). By activating its cognate RANK receptor on the 
surface of the precursors (essentially cells of the monocyte/ macrophage lineage), it triggers 
their fusion and differentiation into mature osteoclasts, thus activating bone resorption 
(Teitelbaum & Ross 2003). On the other hand, OPG is a soluble decoy receptor that blocks 
RANKL, hence preventing its interaction with RANK and all the down-stream events that 
lead to osteoclast differentiation (Simonet et al. 1997). The production of RANKL and OPG 
by various cell types is controlled by systemic and local stimuli, including hormones, 
inflammatory mediators and bacterial products (Lerner 2006, Harokopakis-Hajishengallis 
2007). Members of the IL-1 family of cytokines, as well as prostaglandins, are among the 
most potent inducers of RANKL expression (Liu et al. 2010). The overall efficiency of 
RANKL on osteoclast formation and bone resorption is tightly coupled to the presence and 
levels of its natural inhibitor OPG. Therefore, it is meaningful to study concomitantly the 
expression of these two molecules in sites of suspected hard tissue resorption, preferably as 
their relative RANKL/OPG ratio. 
The involvement of the RANKL-OPG system is well established in the pathogenesis 
of diseases of bone and mineral metabolism, such as rheumatoid arthritis, postmenopausal 
osteoporosis and bone malignancies (Vega et al. 2007), as well as chronic and aggressive 
marginal periodontitis (Taubman et al. 2007, Buduneli & Kinane 2011, Belibasakis & 
Bostanci 2012). Interestingly, an elevated RANKL/OPG ratio has been demonstrated in the 
gingival crevicular fluid (GCF) of sites with periodontitis, compared to gingivitis, or healthy 
sites (Mogi et al. 2004, Bostanci et al. 2007). An increase of the RANKL/OPG ratio can also 
be measured in the GCF of teeth subjected to orthodontic toot movement (Nishijima et al. 
2006). Less conclusive information is available on the involvement of this molecular system 
in pulpal and periapical pathoses, such as pulpitis and apical periodontitis, or its association 
with the clinical presentation of these conditions. The objective of this review was to carefully 
evaluate the involvement of the RANKL-OPG system in the bacterially-induced 
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inflammatory processes in the pulp and periapical region, by summarizing any collective 
evidence on in vitro models, animal experimentations and clinical studies involving human 
material. The question of clinical relevance addressed is whether the RANKL-OPG system is 
differentially regulated in pulpitis and apical periodontitis, and whether this could serve as a 
measure for differential diagnosis between these conditions, or a prognostic biomarker that 
can further predict the progression of bone resorption.  
 
Search strategy 
The search included all published articles relating RANKL and/or OPG to pulpal and/or 
periapical disease. Human, animal, and cell culture studies were all considered. The Medline 
database was searched via the OvidSP search interface with a combined search strategy using 
keyword search and controlled vocabulary (MeSH-terms) as described in Table 1 (for further 
details see Supplement 1). The same strategy was adapted and applied using Biosis (OvidSP), 
the Cochrane library (Wiley), Embase (www.embase.com) and the Web of Science 
(Thompson). Articles from inception of these databases (Medline 1948, Biosis 1980, 
Cochrane 1995, Embase 1974, Web of Science 1899) up to and including October 2011 were 
considered. Publications available in early-online format at the time of the electronic search 
were included in this review. No language restriction was applied. Furthermore, the reference 
lists of the identified articles were searched for further titles. 
 
Selection of publications 
In a first screening step, the two reviewers (GNB and DKR) independently evaluated titles 
and abstracts from the electronic search and assessed these with respect to the exclusion 
criteria applied. Communications were excluded when they were: (a) not related to RANKL 
or OPG; (b) not related to pulpitis or periapical disease; or (c) mere conference abstracts. Any 
title included by either reviewer went further to the second screening step, the full-text 
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evaluation. Both reviewers assessed 40 full texts applying the exclusion criteria mentioned 
above. Two articles included for full-text evaluation were written in Chinese language. These 
were translated by a Chinese researcher proficient in English. Disagreement was resolved by 
discussion and with the help of an experienced referee (MZ). 
 
Search results 
Of the 40 full texts initially included, 7 were excluded because they did not meet the search 
criteria (Fig. 1). Of the 33 included articles, 11 involved laboratory studies on cell cultures, 9 
involved animal experimentations, and 13 were observational studies using human clinical 
samples (Table 2). The following text will review the findings of the identified publications. 
 
Review of identified publications 
In vitro studies 
The first indication that the RANKL-OPG system may be expressed in the pulp region came 
with the in vivo demonstration that these molecules are immunolocalised on the ameloblast, 
odontoblast and pulp layers of neonatal murine teeth (Rani & MacDougall 2000). Further in 
vitro investigation demonstrated that both RANKL and OPG are constitutively expressed in 
murine odontoblasts and dental pulp cells (Rani & MacDougall 2000). Human dental pulp 
cells are also shown to express RANKL (Uchiyama et al. 2009, Belibasakis et al. 2011) and 
OPG (Sakata et al. 1999, Mizuno et al. 2005, Uchiyama et al. 2009, Belibasakis et al. 2011) 
in vitro. Nevertheless, in co-culture with appropriate osteoclast precursors, the murine cells 
failed to induce or even inhibited osteoclast formation (Rani & MacDougall 2000), whereas 
the human pulp cells supported this action (Uchiyama et al. 2009). These findings denote that 
the control of osteoclastogenesis by dental pulp cells could be species-specific.  
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Bacteria are putative regulators of RANKL and OPG in dental pulp cells, with 
potential effect on osteoclast or odontoclast formation. Nevertheless, in vitro studies on this 
topic are very sparse. An in vitro biofilm model consisting of six species representative of the 
supragingival microbiota was investigated for its effects on RANKL and OPG gene 
expression in human dental pulp and periodontal ligament cells. This multi-bacterial 
challenge up-regulated RANKL expression in both dental pulp and periodontal ligament cells, 
but had 4-fold greater effect on the former. Consequently, the relative RANKL/OPG ratio was 
strongly up-regulated in dental pulp cells, an event which could favour bone or dentine 
resorption and contribute to the development of apical periodontitis or internal root resorption 
(Belibasakis et al. 2011). Porphyromonas endodontalis, a black-pigmented anaerobic species 
with high association to endodontic infections (van Winkelhoff et al. 1992) was investigated 
for its effects on RANKL in human osteoblasts, rather than dental pulp cells. A time-
dependent induction of RANKL protein production was observed, which was evident after 4 h 
of challenge with P. endodontalis (Chen et al. 2009). As the regulation of OPG was not 
investigated, it is not possible to conclude on the net effects on the RANKL/OPG ratio. 
Experimental systems using human osteoblasts may still be of relevance to apical 
periodontitis, as endodontic pathogens can well reach the periapical osteoblasts and stimulate 
the production of bone resorbing factors.  
Several inflammatory mediators can also regulate the RANKL-OPG system in dental 
pulp cells. In an early study, interleukin (IL)-1β and tumour necrosis factor (TNF)-α enhanced 
OPG expression by human dental pulp cells at a concentration of 0.5 ng/ml, after 12 h of 
stimulation (Sakata et al. 1999). However, this study failed to detect RANKL expression by 
the cells. These early results would imply a potential role of cytokines on inhibition of dentine 
or bone resorption, despite their pro-inflammatory capacities. However, later studies have 
confirmed the expression of RANKL by dental pulp cells and its regulation by pro-
inflammatory mediators. Both IL-1α and TNF-α, at concentrations of 10 ng/ml, were shown 
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to stimulate RANKL gene and protein expression, in a time-dependent manner. Their co-
administration had a synergistic effect on RANKL expression, but down-regulated OPG 
expression (Kim et al. 2010). These results in dental pulp cells denote that the relative 
RANKL/OPG ratio is up-regulated by pro-inflammatory cytokines, well in line with their 
capacity to stimulate events related to hard tissue resorption. Further on, this work 
demonstrated that cytosolic phospholipase (cPL)A2 was responsible for the induction of PGE2 
and the subsequent induction of RANKL expression (Kim et al. 2010). Substance P, a sensory 
neuropeptide, was shown to stimulate PGE2 and RANKL production by dental pulp cells 
(Kojima et al. 2006). PGE2 partially mediated the induction of RANKL gene expression in 
that experimental system, and its subsequent production by the cells. Conditioned medium 
from these cell cultures stimulated pit formation by osteoclasts on dentine slices. As a 
mediator of pulpal inflammation (Kvinnsland & Heyeraas 1992), substance P may exert its 
role in root or periaplical bone resorption by stimulating RANKL in a PGE2-dependent 
mechanism. Importantly, the findings of this study imply that dental pulp cell-derived 
RANKL supports the formation of functional osteoclasts on dentine. Therefore, it is 
reasonable to speculate that the RANKL-OPG system could control odontoclast formation in 
the dental pulp, thus mediating internal root resorption. However, this remains to be further 
elucidated. 
A number of biological agents could potentially regulate RANKL and OPG expression 
in dental pulp cells. As such, inorganic polyphosphate, a biopolymer with several biological 
functions on eukaryotic cells, has been investigated for its potential effects. Long exposure (3 
weeks) of human dental pulp cells to this agent has been shown to induce a 3.3-fold higher 
OPG expression, compared to the un-stimulated control (Kawazoe et al. 2008). Platelet-rich 
fibrin is a platelet concentrate that resembles a fibrin network and contains a large number of 
growth factors and cytokines, with the potential to enhance wound healing (Dohan et al. 
2006). This agent up-regulated OPG production by dental pulp cells, already one day after 
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stimulation, and persisted over a period of 5 days (Huang et al. 2010). Stem cells isolated 
from human dental pulp have also been considered with regards to OPG expression. These 
were seeded on silk scaffolds and underwent mechanical tension in a bioreactor environment. 
OPG expression was slightly increased in cells under tension (Han et al. 2010). The induction 
of OPG in these studies could indicate a protective effect against dentine or bone resorption, 
and a positive switch of the homeostatic balance towards tissue formation. Nevertheless, 
RANKL was not studied in this context, and therefore the overall regulation of the RANKL-
OPG system cannot be deduced.  
In conclusion, little in vitro evidence is available on the mechanisms of the regulation 
of the RANKL-OPG system in dental pulp cells, or in response to endodontic pathogens. Yet, 
the available information indicates that RANKL and OPG can be regulated by bacterial or 
pro-inflammatory stimuli in these cells, in a manner that favours bone resorption, and possibly 
via the mediation of PGE2. It should be reiterated that future studies in this direction must 
consider the concomitant investigation of RANKL and OPG. Moreover, relatively limited 
information is available on the capacity of dental pulp cells to stimulate odontoclast formation 
via the RANKL-OPG system. This is an open field of study, which could provide answers to 
the molecular mechanisms governing internal root resorption, and needs to be further pursued. 
 
Animal studies 
The first in vivo demonstration of the involvement of the RANKL-OPG system in periapical 
lesions came by immunolocalization studies, in experimental animal models. In particular, 
periapical localization of RANKL was initially investigated in a rat model whereby the pulp 
of the mandibular first molars was experimentally exposed (Zhang & Peng 2005a,b). 
Osteolcast-like cells, which are tartrate-resistant acid phosphatase (or short TRAP)-positive, 
and RANKL-positive cells were observed periapically, already one week after pulpal 
exposure. By end of the second week, dense inflammatory infiltrates and periapical bone 
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resorption was observed, accompanied by a climax in RANKL-positive and osteoclast-like 
cells. After 4 weeks of exposure, although the chronic inflammatory infiltrates were 
established, the presence of these osteoclast-like and RANKL-positive cells was reduced to 
baseline levels, and periapical bone resorption was slowed down (Zhang & Peng 2005a,b). 
This study revealed the involvement of RANKL in periapical bone resorption, and identified 
that the peak of its expression is commensurate with a peak of osteoclast activity and bone 
resorption. This was further confirmed on the mRNA expression level, in a later study using a 
similar experimental system, which also took into account the expressions of OPG and RANK 
(Kawashima et al. 2007). The periapical expression of RANKL peaked after 2 to 3 weeks of 
pulpal exposure, and maintained higher than baseline levels, over a period of 8 weeks. RANK 
and OPG expressions followed a similar kinetic pattern of increase, however not as 
pronounced as RANKL. The enhancement of OPG expression was explained as a 
compensatory mechanism for the rapid induction of RANKL. Nevertheless, the relative 
RANKL/OPG expression ratio peaked over 3 weeks, and persisted at high levels over the 8-
week observational period, suggesting an enhanced capacity for bone resorption. Accordingly, 
expression of pro-inflammatory cytokines IL-1α, IL-1β and TNF-α, with the capacity to 
induce RANKL, also peaked during the interval between 2 and 3 weeks. 
Immunohistochemically, RANKL-positive cells with diverse morphologies were detected in 
the periapical lesion, in close proximity to the alveolar bone and to osteoclast-like cells. These 
were identified as mainly fibroblastic, but a small proportion of T-cells were also evident. 
Therefore, this study demonstrated that a local increase in the RANKL/OPG expression ratio, 
occurring 2 to 3 weeks after pulpal exposure, is concomitant with the expansion of the 
periapical lesion. 
Pulp exposure models in animals allow for the “natural” development of a periapical 
lesion. Molecules such as RANKL and OPG can thus be studied regarding their role in the 
development of hard-tissue lesions in real time. However, some of the animal studies 
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reviewed here may not have taken stringent consideration of the bacterial engagement in this 
process. In a recent variation of this experimental model, the infectious agent was controlled 
by co-administration of Escherichia coli LPS (soaked on a paper-point) into the exposed 
distal root canal of the lower first molars, up to the apex (Chuang et al. 2012). Periapical bone 
resorption, expression and localization of RANKL and OPG, and osteoclast formation were 
followed over a period of 8 weeks. A boost in RANKL expression was observed after 3 weeks 
of exposure, culminating in 208 % of the unexposed pulp control, after 8 weeks. OPG 
expression was fluctuating between weeks 1 and 8, but was detected at lower levels than the 
control group. Accordingly, a very strong induction of the relative RANKL/OPG expression 
ratio was evident at weeks 7 and 8, which was respectively 30 and 41 times higher than the 
control group. Increased localization of both RANKL and OPG in the periapical lesions was 
evident from week 3 onwards, accompanied by an increase in the presence of osteoclast-like 
cells. This model of LPS-induced periapical lesions in the rat provides insights to the 
involvement of RANKL and OPG in this infectious process (Chuang et al. 2012). 
Nevertheless, it is difficult to interpret the relative contribution of LPS, due to the lack of a 
control group where the pulp is exposed, yet not treated with LPS. 
Experimental animal models are amenable to technical manipulations, allowing for the 
study of specific factors in the development of the disease. For instance, ovariectomized rats 
have been used in order to study the relative effect of estrogen deficiency on the synthesis of 
RANKL and OPG, in induced periapical lesions (Zhang et al. 2007). It was found that in the 
ovariectomized rat group, more osteoclasts and more RANKL-positive cells were present, 
than the sham-ovariectomized group, as early as one week after the induction of periapical 
lesion. Nevertheless, OPG production was also increased at early time points in the estrogen-
deficient mice, which by time was reduced to control levels. This is perceived as an early 
protective response of the tissue, in order to compensate against the overproduction of 
RANKL and, consequently, bone resorption. Overall, estrogen deficiency appears to 
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accelerate periapical bone loss, characterised by high local levels of RANKL production 
(Zhang et al. 2007). 
Experimental periapical lesion models have also been utilized in genetically modified 
mice, in order to evaluate the involvement of specific genes in the RANKL or OPG-
associated responses. In a mouse model of endodontic infections, the relative role of 
osteopontin (OPN) was considered (Rittling et al. 2010). OPN is a secreted integrin-binding 
protein that constitutes part of the extracellular matrix of bone. It is also considered to play a 
functional role in immunoregulatory responses. In this model, periapical tissue RANKL 
expression was increased already 3 days after infection, and was more than 2-fold higher in 
the OPN-deficient mice, compared to the wild-type counterparts. After 3 weeks, periapical 
bone loss was significantly more severe in OPN-deficient mice and was characterized by 
dense inflammatory infiltrates. This study revealed a potential negative association between 
OPN and RANKL in endodontic infection, which awaits further investigation (Rittling et al. 
2010). 
In mice lacking the CCR2 chemokine receptor, inoculation of 4 bacterial taxa 
(Porphyromonas gingivalis, Prevotella nigrescens, Actinomyces viscosus, Fusobacterium 
nucleatum) into the pulp resulted in larger periapical lesion formation, compared to the wild-
type mice. After one week of infection, the periapical expression of RANKL was higher, 
whereas that of OPG was lower in the CCR2-deficient mice. Nevertheless, these differences 
were not significant after 2 weeks. This study concluded on a protective role of CCR2 against 
bacterially-induced periapical osteolysis (Garlet et al. 2010). 
The relative role of nitric oxide synthase (iNOS) or phagocyte oxidase (PHOX) in a 
pulp exposure model in mice was also studied (Silva et al. 2011). After two weeks, 
experimental (pulp exposed) iNOS-deficient mice exhibited greater periapical resorption area 
and number of osteoclasts, and higher RANK, RANKL, but not OPG, expression levels, 
compared to wild-type mice. On the contrary, PHOX-deficient mice did not exhibit any 
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periapical osteoclasts and the periapical expressions of RANK, RANKL and OPG were not 
significantly different, compared to the wild-type mice. Collectively, the results of this study 
indicate that nitric oxide, but not reactive oxygen species, are involved in the progression of 
periapical bone resorption (Silva et al. 2011). The role of iNOS-inducible nitric oxide in 
periapical bone resorption has also been demonstrated in an earlier study involving bacterial 
infection of the root canal with the 4 previously mentioned bacterial species (Fukada et al. 
2008). In this study, iNOS-deficient mice with exposed pulp exhibited higher number of 
osteoclasts, and higher RANK, but lower OPG expression, compared to the wild-type 
experimental mice. Periapical RANKL expression was not different between iNOS deficient 
and wild-type mice. Hence, iNOS deficiency was considered as a factor causing an imbalance 
of the bone resorption modulating-factors, and leading to increased infection-induced 
periapical bone resorption. 
In conclusion, the above-described animal studies have mostly involved pulpal 
exposure models to generate periapical lesions, for the study RANKL and OPG localization 
and expression. These studies confirm that this molecular system is also implicated in 
pathological periapical bone resorption, and reveal a locally enhanced RANKL/OPG ratio, in 
line with observations in other bone-destructive pathoses.  However, it is noteworthy that no 
animal experimentations exist in which the RANKL-OPG system is studied within the dental 
pulp, in relation to pulpitis. This is an important gap in our knowledge that needs to be 
fulfilled, as it could reveal mechanisms involved in odontoclast formation and internal root 
resorption. 
 
Human studies 
The systematic search produced 13 publications, which fulfilled the criteria (Table 2). In 
human teeth, RANKL was first identified in pulps of deciduous molars (Lossdörfer et al. 
2002). Immunohistochemistry revealed cytoplasmatic granular staining for RANKL in 
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odontoblasts and pulp fibroblasts in roughly half of the investigated specimens. However, 
RANKL appears to be expressed at much higher levels in pulps of deciduous teeth 
undergoing resorption (i.e. shedding) than in counterparts of healthy permanent teeth 
(Yildirim et al. 2008). In healthy deciduous tooth pulps, OPG is expressed at higher levels 
than RANKL (Yildirim et al. 2006). Only one study was identified that investigated the levels 
of OPG in human pulps of different inflammatory states (Kuntz et al. 2001). This 
investigation revealed intense immunostaining for OPG in the odontoblastic layer of healthy 
pulps. OPG was not detected in the central area of these pulps. In contrast, in inflamed pulps 
challenged by gross dental decay, the central aspects showed intense immunostaining also. 
RANKL levels were not investigated. The steady-state expression of OPG in odontoblasts 
could constitute a protective response of the pulp against imminent inflammatory dentine 
resorption.   
 The remaining 10 publications on RANKL and/or OPG that were identified, dealt with 
periapical inflammation and its possible modulation. A first immunohistochemical study 
showed the presence of RANKL in radicular cysts (Tay et al. 2004). Immunolocalization of 
RANKL was in concordance with cells staining for TRAP, i.e. osteoclasts. A subsequent 
publication confirmed the presence of RANKL at the gene expression level in inflammatory 
periapical lesions of undisclosed nature (Sabeti et al. 2005). RANKL mRNA was also semi-
quantified in periapical granulomas, while it was below detection limit in healthy periodontal 
ligament (Vernal et al. 2006). Expression of RANKL on infiltrate leukocytes was further 
investigated using flow cytometry: monocytes (CD14+) and dendritic cells (CD83+) were the 
main synthesizers of RANKL in granuloma lesions (Vernal et al. 2006). An 
immunohistochemical study compared RANKL and OPG levels between apical granulomas 
and radicular cysts (Menezes et al. 2006). It was found that the ratio of OPG+/total cells and 
that of RANKL+/total cells was higher in granulomas than in cysts. However, the ratio 
between RANKL and OPG-positive cells did not differ between these two types of periapical 
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inflammatory lesion. Again, various cell types stained positive for RANKL and OPG, with 
macrophage-like cells (CD68+) showing the highest intensity. Another investigation 
compared RANKL (but not OPG) mRNA levels between granulomas and cysts, 
demonstrating that its expression was significantly higher in granulomas than in cysts (Fukada 
et al. 2009). One study, however, did not identify any difference between total RANKL or 
OPG protein levels or their ratio between granulomas and radicular cysts (Fan et al. 2008). 
Few human studies have attempted to investigate the role of the RANKL-OPG system 
in endodontic disease initiation or progression. In one investigation, periapical lesions were 
graded according to their inflammatory status (Fan et al. 2011). The authors found 
significantly more RANKL-positive cells in severely inflamed lesions compared to lightly 
inflamed counterparts. However, the RANKL/OPG ratio was statistically similar between 
inflammations graded as light, moderate, or intense. The RANKL/OPG ratio at the gene 
expression levels was also compared between granulomas and periodontal ligament of 
orthodontically moved teeth (Menezes et al. 2008a). Whilst the compression sites of 
orthodontically moved teeth almost consistently showed RANKL mRNA levels to be higher 
than OPG counterparts, and tension sites the reversed ratio, i.e. OPG > RANKL, this ratio was 
inconsistent with granulomas. The upstream transcription of pro-inflammatory cytokine genes 
regulating bone resorption is modulated by a group of molecules termed suppressors of 
cytokine signalling (SOCS) (Starr et al. 1997). In granulomas, it was shown that RANKL 
gene expression is negatively correlated to SOCS1 mRNA levels (Menezes et al. 2008b). 
Only one human study attempted to correlate the presence of infective agents, namely 
cytomegalovirus and Epstein-Barr virus, to RANKL gene expression in granulomas (Yildirim 
et al. 2006). Whilst there was a higher occurrence of these viruses in the periapical lesions 
compared to healthy pulp tissues, no correlation was found between their presence and 
RANKL.  
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Discussion 
This comprehensive review showed that, as of yet, relatively little information is available 
regarding the specific involvement of the RANKL/OPG system in the progress of pulpal and 
periapical disease. On the positive side, animal studies have unveiled a relatively clear-cut 
timeline, during which the RANKL/OPG ratio is up-regulated in the periapical tissues after a 
microbial challenge from the infected pulp space. However, little is known as to what happens 
in the pulp space itself. There is also ample space for more in vitro and human studies to 
further understand the molecules under investigation in the context of pulpal and periapical 
pathophysiology. The following text will discuss these issues according to the type of study.  
Prior to that, it should be clarified that resorptive processes in cementum and dentine from the 
periodontal side were not included in the search, as this would have widened the focus of the 
question beyond the pulpal and/or periapical disease induced by pulpal infection. However, 
internal resorption was included, because it is clearly related to these infectious processes 
(Gabor et al. 2012). 
 
In vitro studies 
It is well known that RANKL and OPG can be expressed by various cell types, and thus, in 
vitro research on pulp cell cultures yields relatively little cutting edge information unless it 
reveals new insights into the expression, translation, and activation of these molecules. For 
instance, a point worth investigating is the “shedding” of RANKL from the surface of the 
dental pulp cells, which could have detrimental effects on dentine resorption, within the 
confined space of the pulp chamber. In this extent, TNF-α-converting enzyme (TACE) is the 
metalloproteinase with the highest specificity for cleaving and releasing (i.e. shedding) 
RANKL from the cell surface into the extracellular environment (Lum et al. 1999). TACE 
production can be stimulated in T-cells by P. gingivalis (Bostanci et al. 2009), and its GCF 
levels are elevated in periodontitis and correlate positively with RANKL levels (Bostanci et 
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al. 2008). In human dental pulp cell cultures, it was shown that TACE gene expression is up-
regulated in response to challenge with in vitro supragingival biofilms (Belibasakis et al. 
2011). It is therefore worth investigating, in the context of the dental pulp, the shedding of 
RANKL by TACE or other sheddases, and its subsequent effects on odontoclast formation 
and dentine resorption.  
Apart from the investigation of regulation of the RANKL-OPG system in the 
endodontic context, it should also be reiterated that more emphasis is to be put on its potential 
implication in odontoclast formation and dentine resorption during the course of pulpitis, even 
though this is a more rare pathology. In fact, this is highly feasible if one considers that the 
standard laboratory model to study osteoclastic “bone” resorption in vitro is actually 
performed on sterile dentine slice preparations, obtained from i.e. from elephant tusks 
(Tamura et al. 1993, Agrawal et al. 2012). 
 
Animal studies 
In general, the available animal studies considering the RANKL-OPG system have focused on 
the development of periapical lesions, whilst the study of pulpal disease has been neglected in 
this respect. The role of the RANKL and OPG within the dental pulp, and their involvement 
in human pulpitis and pulpal breakdown remains therefore somewhat enigmatic. Considering 
the regulation of RANKL and OPG during the course of experimental pulpitis may reveal a 
protective role of OPG against internal dentine resorption. The high levels of OPG in the 
odontoblast layer of healthy human pulps may suggest a role of this cell zone in the protection 
of the root canal wall from internal resorption (Kuntz et al. 2001). Small internal resorptions 
are a common sequel to pulpitis (Gabor et al. 2012). However, the expression of OPG in 
odontoblasts may protect the canal wall from clinically manifest internal resorptions, which 
are extremely rare and appear only to occur in cases of chronic pulpitis, i.e. when the 
inflammatory stimulus persists without complete tissue breakdown for extended periods of 
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time (Patel et al. 2010). Studies to understand the phenomenon of internal root resorptions in 
the context of the RANKL-OPG system are definitely warranted and should be performed. In 
support of this notion, evidence already exists on the participation of this system in the events 
associated with external root resorption, for instance in the case of orthodontic tooth 
movement (Low et al. 2005, Yamaguchi et al. 2006, Tyrovola et al. 2010, Nakano et al. 2011, 
Zhou et al. 2011). 
Regarding the role of RANKL-OPG in periapical tissue remodelling, a most recent 
study (not identified by the current search because published later) investigated germ-free 
mice, which were exposed to a known bacterial challenge (Maciel et al. 2012). After pulpal 
exposure of the maxillary first molars, suspensions of Fusobacterium nucleatum, or 
Peptostreptococcus prevotii, or mixture of both, were inoculated into the root canals, and 
followed for up-to 2 weeks. In the mono-infected groups, RANKL expression was similar, 
whereas in the dual infection group this became significantly reduced after 2 weeks. As that 
study did not include a non-infected group, it is difficult to evaluate the relative contribution 
of the two tested species in RANKL induction. However, a potential competitive interaction 
was revealed, as the co-infection with these two species resulted in reduced RANKL 
expression. When considering the cells that participate in RANKL-induced periapical bone 
destruction, the role of T-cells is highlighted (Silva et al. 2012). Pulp exposure of the lower 
first molars in mice resulted in formation of periapical lesion and a remarkable infiltration of 
CD3-positive T-cells after one week, followed by remission by the end of the second week. 
More than 50 % of these T-cells were also RANKL-positive. The concomitant presence of 
endodontic pathogens was also investigated in the pulp exposure / periapical lesion model, by 
16S rRNA sequencing. Pasteurella pneumotropica and Enterococcus saccharolyticus were 
consistently found in the exposed root canals. The systemic IgG response to P. pneumotropica 
was significantly elevated in the experimental mice group. Moreover, mice immunized with 
this species exhibited in their lymph nodes T-cells with high antigenic species-specific 
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responses, including proliferation and RANKL production. Hence, this study indicates that 
endodontic bacteria colonizing the root canal may induce RANKL expression by activated T-
cells, and denotes a pathway by which the adaptive immune responses can induce periapical 
bone resorption (Silva et al. 2012).  
 
Human studies 
No human study thus far could clearly correlate the RANKL-OPG system to a clinical 
condition. Apart from its important role in understanding the molecular mechanisms of hard 
tissue resorption, this system could prove to be an interesting marker to indicate periapical 
healing after cleaning and shaping of the root canal system. The advantage of this system is 
that it is, according to animal studies, clearly related to inflammatory disease progression in 
the periapical area. The antagonistic action of the two proteins makes the relation of their 
expression to total protein or other internal controls unnecessary. Instead, the RANKL/OPG 
ratio can be determined at the protein level, within each sampled lesion. Therefore, when 
comparing different lesions for the RANKL/OPG ratio, any quantitative variations between 
sample volumes can be eliminated. However, clinical studies investigating this possibility are 
currently missing and should be performed. 
 
Conclusion 
While much research has been performed on the RANKL-OPG system in other fields such as 
periodontitis, few studies have addressed questions that could improve our specific 
understanding of pulpal and periapical disease. In this context, further investigations should 
elucidate the function of OPG in the odontoblastic layer and its potential role in the protection 
from internal resorption. Furthermore, clinical studies are warranted to investigate the 
potential of the RANKL/OPG ratio as an early marker of periapical healing, as well as its 
association to presence or absence of bacteria, after cleaning and shaping of the root canal 
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system. Prospective studies measuring the concentrations of RANKL and OPG, as well as 
their relative ratio, in periapical fluid obtained through the root canal may reveal a differential 
production pattern between pulpitis and chronic or symptomatic apical periodontitis. This 
could denote differences in the time-line of periapical bone resorption activity and may confer 
additional molecular diagnostic value for periapical pathoses. 
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Table 1 Example of search strategy (here in Medline database) used in the literature review.  
 
 
Number Search history Results 
1 RANK Ligand/ or Osteoprotegerin/ 
 
4847 
2 ("tumor necrosis factor ligand superfamily member 11" or trance 
protein or "receptor activator of nuclear factor-kappa b ligand" or 
"receptor activator of nuclear factor kappab ligand" or "receptor 
activator of nuclear factor kappa b ligand" or "tumor necrosis factor 
related activation induced cytokine" or "tumor necrosis factor-
related activation-induced cytokine" or "osteoclast differentiation 
factor" or "opgl protein" or "osteoprotegerin ligand" or "rankl 
protein" or "rank ligand" or "follicular dendritic cell derived 
receptor 1" or "follicular dendritic cell-derived receptor-1" or 
"osteoclastogenesis inhibitory factor" or "ocif protein" or "fdcr 1 
protein" or "fdcr-1 protein" or osteoprotegerin or tnfsf11 or 
tnfrsf11b).mp. 
 
5854 
3 (OPG and ("gene expression" or "mRNA expression" or "protein 
expression" or "gingival crevicular fluid" or saliva or serum or 
plasma)).mp. 
 
1368 
4 
 
5 
 
6 
 
 
 
 
7 
 
(trance adj5 (protein or expression or activation or pathway)).mp. 
 
or/1-4 
 
(exp Dental Pulp/ or exp Pulpitis/ or exp Dental Pulp Cavity/ or exp 
Endodontics/ or (pulp or pulpitis or endodontic or "root canal" or 
apical or periapical).mp.) 
pulpitis.mp. or exp Pulpitis/ 
 
5 and 6 
 
74 
 
5925 
 
100050 
 
 
 
 
57 
 
 
 26 
 
Table 2 Classification of all publications included to the review (N=33) 
 
In vitro studies (N=11) Animal studies (N=9) Human studies (N=13) 
Belibasakis et al. 2011 
Chen et al. 2009 
Han et al. 2010 
Huang et al. 2010 
Kawazoe et al. 2008 
Kim et al. 2010  
Kojima et al. 2006  
Mizuno et al. 2005 
Rani & MacDougall 2000 
Sakata et al. 1999 
Uchiyama et al. 2009 
 
Chuang et al. 2011 
Fukada et al. 2008 
Garlet et al. 2010 
Kawashima et al. 2007 
Rittling et al. 2009 
Silva et al. 2011  
Zhang & Peng 2005a 
Zhang & Peng 2005b 
Zhang et al. 2007 
 
 
 
Fan et al. 2008 
Fan et al. 2011 
Fukada et al. 2009 
Kuntz et al. 2006 
Lossdörfer et al. 2001 
Menezes et al. 2006 
Menezes et al. 2008a 
Menezes et al. 2008b 
Sabeti et al. 2005 
Tay et al. 2004 
Vernal et al. 2006 
Yildrim et al. 2006 
Yildrim et al. 2008 
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Figure 1 Flow chart depicting the primary inclusion and subsequent exclusion of articles 
related to the current topic. 
 
 
